Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.

Original publication

DOI

10.1016/j.stem.2007.11.003

Type

Journal article

Journal

Cell Stem Cell

Publication Date

13/12/2007

Volume

1

Pages

595 - 596

Keywords

Animals, Antigens, CD, Disease Models, Animal, Glycoproteins, Humans, Mice, Muscular Dystrophies, Peptides, Stem Cell Transplantation, Stem Cells, Transduction, Genetic, Transplantation, Autologous, Transplantation, Heterologous